Else Nutrition Holdings Inc.
Other OTCRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Else Nutrition Holdings Inc. (TSX:BABY; OTC:BABYD) is a plant-based nutrition company focused on the research, development, manufacturing, marketing and sale of clean-label, whole-food products for infants, toddlers, children and adults. The company offers plant-based complete nutrition formulas made from almonds, buckwheat and tapioca; baby and toddler snacks; complementary foods; toddler drinks for ages 12-36 months; follow-on formulas; and baby feeding accessories including sterile and non-sterile feeding bottles, teats and disposable nipples. Its products, which exclude dairy, soy, gluten, GMOs, corn syrup, palm oil and artificial ingredients, target consumers seeking alternatives for dietary restrictions, sensitive tummies and plant-based lifestyles, and are distributed through online channels and select retailers in North America, Israel, Australia and New Zealand. Founded in 2012 and headquartered at 6 Hanechoshet Street in Tel Aviv, Israel, with additional offices in Vancouver, British Columbia, Canada, the company employs approximately 13 people and reports sales across vitamins and nutrition products, with 2024 geographic revenue primarily from the United States (CAD 6.17 million), Canada (CAD 937,000) and Israel (CAD 856,000). Recent developments include a November 2025 convertible security funding agreement with Lind Global Fund III LP, managed by The Lind Partners LLC, for gross proceeds of up to US$1.28 million to support production and operations; and a December 2025 five-year renewal of a tender with Israel's largest health fund for nationwide supply of baby feeding accessories to hospitals and maternity wards, securing approximately 7% of 2024 revenue.
ELSE NUTRITION ANNOUNCES FURTHER EXTENSION OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
Else Nutrition CEO to Present at Investor Summit Virtual on December 9, 2025
Else Nutrition Secures Five-Year Renewal of Israel's Largest Health Fund Tender for Baby Feeding Solutions
Else Nutrition Announces Major Breakthrough: President Trump Signs Pivotal FDA Funding Package that Includes Congressional Directive Streamlining Regulatory Pathway for Non-Dairy, Non-Soy Plant-Based Infant Formula
Else Nutrition Reports Significant Operational Turnaround in Q3 2025 with Gross Margin Expansion and Cost Reduction
Else Nutrition Reschedules 2025 Third Quarter Business Update Conference Call
Else Nutrition Schedules 2025 Third Quarter Business Update Conference Call
ELSE NUTRITION ANNOUNCES SHARE CONSOLIDATION
Else Nutrition Holdings Inc. (BABY:CA) Q2 2025 Earnings Call Transcript
Else Nutrition Reports 2025 Second Quarter Financial Results and Provides Business Update
Else Nutrition Schedules 2025 Second Quarter Business Update Conference Call
Else Nutrition Reports 2025 First Quarter Financial Results and Provides Business Update
Else Nutrition Schedules 2025 First Quarter Business Update Conference Call
ELSE NUTRITION ANNOUNCES FURTHER EXTENSION OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
Else Nutrition Applauds Pivotal U.S. Legislative Support for Plant-Based, Non-Soy, Non-Dairy Infant Formula Innovation
ELSE NUTRITION ANNOUNCES DELAY IN FILING FINANCIAL STATEMENTS AND EXTENSION OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
Else Nutrition Applauds U.S. Government's Historic Shift in Infant Formula Rules, Unlocking Path to Commercialize the World's First Whole-Food, Dairy-Free Infant Formula
Else Nutrition Reports 2024 Fiscal Year Financial Results and Provides Business Update
Else Nutrition CEO Highlights Urgent Need for Infant Formula Alternatives in The Washington Times Op-Ed
Else Nutrition Expands Nationwide with Kids Ready-to-Drink Shakes in 1,000 Leading U.S. Retailer Stores